BIO vs STEP · rev $2.58B vs rev $1.99B
BIO (BIO) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
BIO currently screens at market cap $0. STEP currently screens at market cap $5.78B.
Not investment advice. Open the BIO and STEP stock pages for the full models.
Not investment advice.